Optimal structural design of mannosylated nanocarriers for macrophage targeting

Journal of Controlled Release

Volumn 194, Issue , 2014, Pages 341-349

  Chen, Peiming ^a,d   Zhang, Xiaoping ^a   Jia, Lee ^b   Prud'Homme, Robert K ^c   Szekely, Zoltan ^a   Sinko, Patrick J ^a  

^a RUTGERS UNIVERSITY   (United States)

^b FUZHOU UNIVERSITY   (China)

^c Princeton University   (United States)

^d CPSC Dophen Corporation   (United States)

Author keywords

Drug delivery; HIV 1; Ligand design; Mannose receptor; Nanocarrier

Indexed keywords

CELL MEMBRANES; CELLS; CYTOLOGY; DRUG DELIVERY; ECONOMIC AND SOCIAL EFFECTS; MACROPHAGES; MOLECULAR BIOLOGY; MOTION PICTURE EXPERTS GROUP STANDARDS; POLYETHYLENE GLYCOLS; STRUCTURAL DESIGN;

CELL SURFACE RECEPTORS; HIV-1; LIGAND DESIGN; MANNOSE RECEPTORS; NANOCARRIERS; OPTIMAL STRUCTURAL DESIGNS; STRUCTURAL CONFIGURATIONS; TEMPERATURE DEPENDENT;

STRUCTURAL OPTIMIZATION;

MACROGOL; MANNOSE; MANNOSE BINDING PROTEIN; MANNOSE RECEPTOR; NANOCARRIER; DRUG CARRIER; MACROGOL DERIVATIVE; NANOPARTICLE; NITRIC OXIDE; POLYMER;

ANIMAL CELL; ARTICLE; CELL LYSATE; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; ENDOCYTOSIS; FLUORESCENCE MICROSCOPY; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MACROPHAGE; MOLECULAR WEIGHT; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PARTICLE SIZE; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PROCESS OPTIMIZATION; PROTEIN BINDING; RAT; SYNTHESIS; TEMPERATURE DEPENDENCE; ANIMAL; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; METABOLISM; MOUSE;

ANIMALS; CELL LINE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; ENDOCYTOSIS; MACROPHAGES; MACROPHAGES, PERITONEAL; MANNOSE; MICE; MODELS, MOLECULAR; NANOPARTICLES; NITRIC OXIDE; POLYETHYLENE GLYCOLS; POLYMERS; RATS;

EID: 84907762303     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.09.006     Document Type: Article

References (65)

1. E. Cassol, L. Cassetta, M. Alfano, and G. Poli Macrophage polarization and HIV-1 infection J. Leukoc. Biol. 87 2010 599 608
2. S. Gordon Alternative activation of macrophages Nat. Rev. Immunol. 3 2003 23 35
3. R. Medzhitov Origin and physiological roles of inflammation Nature 454 2008 428 435
4. F.O. Martinez, A. Sica, A. Mantovani, and M. Locati Macrophage activation and polarization Front. Biosci. 13 2008 453 461
5. D.L. Laskin, R.S. Vasanthi, R.G. Carol, and J.D. Laskin Macrophage and tissue injury: agents of defense or destruction? Annu. Rev. Pharmacol. Toxicol. 51 2011 267 288
6. M. Benoit, B. Dennues, and J.L. Mege Macrophage polarization in bacterial infections J. Immunol. 181 2008 3733 3739
7. K. Shimada Immune system and antherosclerotic disease - heterogeneity of leukocyte subsets participating in the pathogenesis of antherosclerosis Circ. J. 73 2009 994 1001
8. L.K. Heilbronn, and L.V. Campbell Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity Curr. Pharm. Des. 14 2008 1225 1230
9. A. Sica, P. Larghi, A. Mancino, L. Rubino, C. Porta, M.G. Totaro, M. Rimoldi, S.K. Biswas, P. Allavena, and A. Mantovani Macrophage polarization in tumour progression Semin. Cancer Biol. 18 2008 349 355
10. G. Herbein, and A. Varin The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology 7 2010 33
11. H.M. Wilson, R.N. Barker, and L.P. Erwig Macrophages: promising targets for the treatment of atherosclerosis Curr. Vasc. Pharmacol. 7 2009 234 243
12. T. Thepen, M. Huhn, G. Melmer, M.K. Tur, and S. Barth Fcgamma receptor 1 (CD64), a target beyond cancer Curr. Pharm. Des. 15 2009 2712 2718
13. V. Vielhauer, O. Kulkarni, C.A. Reichel, and H.J. Anders Targeting the recruitment of monocytes and macrophages in renal disease Semin. Nephrol. 30 2010 318 333
14. A.M. Brynskikh, Y. Zhao, R.L. Mosley, S. Li, M.D. Boska, N.L. Klyachko, A.V. Kabanov, H.E. Gendelman, and E.V. Batrakova Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease Nanomedicine (Lond.) 5 2010 379 396
15. H. Dou, C.B. Grotepas, J.M. McMillan, C.J. Destache, M. Chaubal, J. Werling, J. Kipp, B. Rabinow, and H.E. Gendelman Macrophage delivery of nanoformulated antiretroviral drugs to the brain in a murine model of neutoAIDS J. Immunol. 183 2009 661 669
16. M. Magnani, L. Rossi, A. Fraternale, L. Silvotti, F. Quintavalla, G. Piedimonte, D. Matteucci, F. Baldinotti, and M. BEndinelli Feline immunodeficiency virus infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5′-triphosphate-loaded erythrocytes AIDS Res. Hum. Retroviruses 10 1994 1179 1186
17. M. Aouadi, G.J. Tesz, S.M. Nicoloro, M. Wang, M. Chouinard, E. Soto, G.R. Ostroff, and M.P. Czech Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation Nature 2009 1180 1184
18. L. Rossi, S. Serafini, F. Pierige, A. Antonelli, A. Cerasi, A. Fraternale, L. Chiarantini, and M. Magnani Erythrocyte-based drug delivery Expert Opin. Drug Deliv. 2005 311 322
19. F. Pierige, S. Serafini, L. Rossi, and M. Magnani Cell-based drug delivery Adv. Drug Deliv. Rev. 60 2008 286 295
20. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160
21. M.V. Pasquetto, L. Vecchia, D. Covini, R. Digilio, and C. Scotti Targeted drug delivery using immunoconjugates: principles and applications J. Immunother. 34 2011 611 628
22. M.S. Mufamadi, V. Pillay, Y.E. Choonara, L.C. Du Toit, G. Modi, D. Naidoo, and V.M. Ndesendo A review on composite liposomal technologies for specialized drug delivery J. Drug Deliv. 2011 2011 (article ID: 939851)
23. N.T. Huynh, C. Passirani, P. Saulnier, and J.P. Benoit Lipid nanocapsules: a new platform for nanomedicine Int. Pharm. 379 2009 201 209
24. M. Rawat, D. Singn, S. Saraf, and S. Saraf Nanocarriers: promising vehicle for bioactive drugs Biol. Pharm. Bull. 29 2006 1790 1798
25. F.M. Veronese, and A. Mero The impact of PEGylation on biological therapies BioDrugs 22 2008 315 329
26. M. Hamidi, A. Azadi, and P. Rafiei Pharmacokinetic consequences of pegylation Drug Deliv. 13 2006 399 409
27. S.M. monghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice 53 2001 283 318
28. P.R. Taylor, L. Martinez-Pomares, M. Stacey, H.H. Lin, G.D. Brown, and S. Gordon Macrophage receptors and immune recognition Annu. Rev. Immunol. 23 2005 901 944
29. J.M. Irache, H.H. Salman, C. Gamazo, and S. Espuelas Mannose-targeted systems for the delivery of therapeutics Expert Opin. Drug Deliv. 8 2008 703 724
30. R.K. Shukla, and A. Tiwari Carbohydrate molecules: an expanding horizon in drug delivery and biomedicine Crit. Rev. Ther. Drug Carrier Syst. 28 2011 255 292
31. A.M. Kerrigan, and G.D. Brown C-type lectins and phagocytosis Immunobiology 214 2009 562 575
32. S.M. D'Addio, S. Baldassano, L. Shi, L. Cheung, D.H. Adamson, M. Bruzek, J.E. Anthony, D.L. Laskin, P.J. Sinko, and R.K. Prud'homme Optimization of cell receptor-specific targeting through multivalent surface decoration of polymeric nanocarriers J. Control. Release 168 2013 41 49
33. G. Kragol, and L. Otvos Orthogonal solid-phase synthesis of tetramannosylated peptide constructs carrying three independent branched epitopes Tetrahedron 57 2001 957 966
34. D.J. Vigerust, S. Vick, and V.L. Shepherd Characterization of functional mannose receptor in a continuous hybridoma cell line BMC Immunol. 13 2012 51
35. E. Cassol, M. Alfano, P. Biswas, and G. Poli Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence J. Leukoc. Biol. 80 2006 1018 1030
36. O. Llorca Extended and bent conformations of the mannose receptor family Cell. Mol. Life Sci. 65 2008 1302 1310
37. H. Feinberg, S. Park-Snyder, A.R. Kolatkar, C.T. Heise, M.E. Taylor, and W.I. Weis Structure of a C-type carbohydrate recognition domain from the macrophage mannose receptor J. Biol. Chem. 275 2000 21539 21548
38. D.T. Vistica, P. Skehan, D. Scudiero, A. Monks, A. Pittman, and M.R. Boyd Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production Cancer Res. 51 1991 2515 2520
39. G.E.P. Box, and D.W. Behnken Some New three level designs for the study of quantitative variables Technometrics 2 1960 455 475
40. R. Gannu, C.R. Palem, S.K. Yamsani, V.V. Yamsani, and M.R. Yamsani Enhanced bioavailability of buspirone from reservoir-based transdermal therapeutic system, optimization of formulation employing Box-Behnken statistical design AAPS PharmSciTech 11 2010 976 985
41. X. Zeng, C.A. Andrade, M.D. Oliveira, and X.L. Sun Carbohydrate-protein interactions and their biosensing applications Anal. Bioanal. Chem. 402 2012 3161 3176
42. R.T. Lee, T.L. Hsu, S.K. Huang, S.L. Hsieh, C.H. Wong, and Y.C. Lee Survey of immune-related, mannose/fucose-binding C-type lectin receptors reveals widely divergent sugar-binding specificities Glycobiology 21 2011 512 520
43. W.I. Weis, and K. Drickamer Structural basis of lectin-carbohydrate recognition Annu. Rev. Biochem. 65 1996 441 473
44. F. Sansone, and A. Casnati Multivalent glycocalixarenes for recognition of biological macromolecules: glycocalyx mimics capable of multitasking Chem. Soc. Rev. 42 2013 4623 4639
45. M. Mammen, S. Choi, and G.M. Whitesides Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors Angew. Chem. Int. Ed. 37 1998 2754 2794
46. C. Fred Brewer Binding and cross-linking properties of galectins Biochim. Biophys. Acta 1572 2002 255 262
47. M.S. Itano, C. Steinhauer, J.J. Schmied, C. Forthmann, P. Liu, A.K. Neumann, N.L. Thompson, P. Tinnefeld, and K. Jacobson Super-resolution imaging of C-type lectin and influenza hemagglutinin nanodomains on plasma membranes using blink microscopy Biophys. J. 102 2012 1534 1542
48. Y. Su, T. Bakker, J. Harris, C. Tsang, G.D. Brown, M.R. Wormald, S. Gordon, R.A. Dwek, P.M. Rudd, and L. Martinex-Pomares Glycosylation influences the lectin activities of the macrophage mannose receptor J. Biol. Chem. 280 2005 32811 32820
49. L.Y. Bourguignon, and S.J. Singer Transmembrane interactions and the mechanism of capping of surface receptors by their specific ligands Proc. Natl. Acad. Sci. U. S. A. 74 1977 5031 5035
50. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160
51. A. Aderem, and D.M. Underhill Mechanisms of phagocytosis in macrophages Annu. Rev. Immunol. 17 1999 593 623
52. V. Le Cadec, L.J. Emorine, I. Toesca, C. Cougoule, and I. Maridonneau-Parini The human macrophage mannose receptor is not a professional phagocytic receptor J. Leukoc. Biol. 77 2005 934 943
53. A. El-Sayed, S. Futaki, and H. Harashima Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment AAPS J. 11 2009 13 22
54. G. Rutili, and K.E. Arfors Protein concentration in interstitial and lymphatic fluids from the subcutaneous tissue Acta Physiol. Scand. 99 1977 1 8
55. B.J. Barber, T.J. Schultz, and D.L. Randlett Comparative analysis of protein content in rat mesenteric tissue, peritoneal fluid, and plasma Am. J. Physiol. 258 1990 714 718
56. R. Pedrinelli, G. Dell'Omo, S. Bandnelli, G. Penno, and M. Mariani Transvascular albumin leakage and forearm vasodilatation to acetylcholine in essential hypertension Am. J. Hypertens. 13 2000 256 261
57. G. Pasut, and F.M. Veronese State of the art in PEGylation: the great versatility achieved after forty years of research J. Control. Release 161 2012 461 472
58. D.A. Herold, K. Keil, and D.E. Bruns Oxidation of polyethylene glycols by alcohol dehydrogenase Biochem. Pharmacol. 38 1989 73 76
59. A. Bendele, J. Seely, C. Richey, G. Sennello, and G. Shopp Short communication: renal tubular vacuolation in animals treated with polyethylene-glycol-conjugated proteins Toxicol. Sci. 42 1998 152 157
60. W.S. Cho, M. Cho, J. Jeong, M. Choi, H.Y. Cho, B.S. Han, S.H. Kim, H.O. Kim, Y.T. Lim, and B.H. Chung Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles Toxicol. Appl. Pharmacol. 236 2009 16 24
61. R. Duncan, and S.C. Richardson Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges Mol. Pharm. 9 2012 2380 2402
62. S. Gunaseelan, S. Pooyan, P. Chen, M. Samizadeh, M.S. Palombo, S. Stein, X. Zhang, and P.J. Sinko Multimeric peptide-based PEG nanocarriers with programmable elimination properties Biomaterials 30 2009 5649 5659
63. A. Cambi, M.G. Netea, H.M. Mora-Montes, N.A. Gow, S.V. Hato, D.W. Lowman, B.J. Kullberg, R. Torensma, D.L. Williams, and C.G. Figdor Dendritic cell interaction with Candida albicans critically depends on N-linked mannan J. Biol. Chem. 283 2008 20590 20599
64. C. Feriotti, V.L. Flavio, E.F. de Araujo, T.A. da Costa, and V.L. Calich Mannosyl-recognizing receptors induce an M1-like phenotype in macrophages of susceptible mice but an M2-like phenotype in mice resistant to a fungal infection PLoS One 8 2013 e54845
65. S. Gunaseelan, K. Gunaseelan, M. Deshmukh, X. Zhang, and P.J. Sinko Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs Adv. Drug Deliv. Rev. 62 2010 518 531